Sakar Healthcare Limited
SAKAR.NS
Get informed when a big investor buys or sells
+ FollowMarket Cap$22.2B
Close$
Share Statistics
| Market cap | $22.20 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $13.7 |
| Beta | 0.38 |
| Outstanding Shares | 22,249,910 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 62.32 |
|---|---|
| PEG | 51.86 |
| Price to Sales | 8.05 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Sakar Healthcare Limited
435 employees
CEO: Sanjay Surendra Shah Sakar Healthcare Limited, founded in 2004 and based in Ahmedabad, India, is a pharmaceutical company actively involved in the full spectrum of drug development, from research and manufacturing to marketing its products. The company's div...